Ligand validation:5DDC

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5DDC_EPE_A_608	37%	5%	0.2	0.899	2.32	2.94	2	12	2	0	100%	0.5
4GPQ_EPE_A_604	80%	21%	0.117	0.965	0.85	2.44	1	7	0	0	100%	0.62
4GQ4_EPE_A_607	50%	8%	0.182	0.933	2.62	2.12	2	5	2	0	100%	0.5
4X5Y_EPE_A_610	39%	4%	0.197	0.904	2.42	3.12	2	10	0	0	100%	0.6
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	44%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	15%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	26%	0.063	0.987	0.79	2.15	1	6	1	0	100%	1
4WYD_EPE_B_503	98%	44%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.